| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917795 | Radiotherapy and Oncology | 2016 | 7 Pages |
Abstract
The combination of vorinostat 400Â mg daily M-F and capecitabine 1000Â mg q12 M-F with radiation (30Â Gy in 10 fractions) was well tolerated with encouraging median overall survival.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Emily Chan, Lori R. Arlinghaus, Dana B. Cardin, Laura Goff, Jordan D. Berlin, Alexander Parikh, Richard G. Abramson, Thomas E. Yankeelov, Scott Hiebert, Nipun Merchant, Srividya Bhaskara, Anuradha Bapsi Chakravarthy,